Hepatitis B Global Clinical Trials Review, H2, 2014

Date: November 28, 2014
Pages: 134
Price:
US$ 2,500.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: H0D716CE752EN
Leaflet:

Download PDF Leaflet

Hepatitis B Global Clinical Trials Review, H2, 2014
Hepatitis B Global Clinical Trials Review, H2, 2014

SUMMARY

GlobalData's clinical trial report, “Hepatitis B Global Clinical Trials Review, H2, 2014' provides data on the Hepatitis B clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hepatitis B. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hepatitis B. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

SCOPE
  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)
REASONS TO BUY
  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Introduction
Hepatitis B
Report Guidance
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by G7 Countries: Proportion of Hepatitis B to Infectious Disease Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of Hepatitis B to Infectious Disease Clinical Trials
Clinical Trials by Phase in E7 Countries
Clinical Trials in E7 Countries by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Unaccomplished Trials of Hepatitis B
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in Hepatitis B Therapeutics Clinical Trials
Prominent Drugs
Latest Clinical Trials News on Hepatitis B
Nov 10, 2014: TetraLogic Pharmaceuticals Announces Results Of Preclinical Studies In Hepatitis B
Nov 10, 2014: Novira Therapeutics Announces Presentation of Phase 1a Safety and Pharmacokinetic Data for NVR 3-778
Nov 10, 2014: Dynavax Announces Independent DSMB Recommendation to Continue Phase 3 Study of HEPLISAV-B
Oct 21, 2014: Hepatera Announces Proof-of-Concept Clinical Results with Myrcludex B, a Novel Entry Inhibitor for Treatment of Chronic Hepatitis B and Delta
Oct 15, 2014: Tekmira Presents Results Of Preclinical Studies With Hepatitis B Therapeutic
Oct 09, 2014: Tekmira to Present HBV Pre-Clinical Data at Meeting of the Oligonucleotide Therapeutics Society
Oct 08, 2014: Arrowhead to Present ARC-520 Phase 2a Data in Late-Breaking Session at AASLD Liver Meeting 2014
Oct 07, 2014: REPLICor to Present Updated Clinical Trial Data of REP-9-AC at the 10th Annual Meeting of the Oligonucleotide Therapeutics Society (OTS)
Oct 01, 2014: REPLICor announces initiation of its Phase II clinical trial with REP 2139-Ca in combination with Pegasys in patients with hepatitis B / hepatitis D co-infection
Sep 25, 2014: Radiant Research/Clinical Research Advantage Enrolls More Than 8,000 Subjects for Hepatitis B Vaccine Study
Sep 22, 2014: Dynavax Completes Enrollment of Phase 3 Study of HEPLISAV-B
Sep 04, 2014: Novira Therapeutics Announces Successful Completion of Phase 1a Clinical Study of NVR-1221 and Commencement of Phase 1b Clinical Studies
Aug 27, 2014: TetraLogic Pharmaceuticals to Present Data From Pre-Clinical Studies With Hepatitis B at the 2014 International Meeting on Molecular Biology of Hepatitis B Viruses
Aug 27, 2014: Green Cross Initiates Phase II Trial of Investigational Recombinant Hepatitis B Immune Globulin
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
GlaxoSmithKline plc
Clinical Trial Overview of GlaxoSmithKline plc
Gilead Sciences, Inc.
Clinical Trial Overview of Gilead Sciences, Inc.
F. Hoffmann-La Roche Ltd.
Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
Merck & Co., Inc.
Clinical Trial Overview of Merck & Co., Inc.
Bristol-Myers Squibb Company
Clinical Trial Overview of Bristol-Myers Squibb Company
Novartis AG
Clinical Trial Overview of Novartis AG
Sanofi
Clinical Trial Overview of Sanofi
Bukwang Pharm.Co., Ltd.
Clinical Trial Overview of Bukwang Pharm.Co., Ltd.
Dynavax Technologies Corporation
Clinical Trial Overview of Dynavax Technologies Corporation
LG Life Sciences, Ltd.
Clinical Trial Overview of LG Life Sciences, Ltd.
Clinical Trial Overview of Top Institutes / Government
National Taiwan University Hospital
Clinical Trial Overview of National Taiwan University Hospital
The National Institute of Diabetes and Digestive and Kidney Diseases
Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases
The National Institute of Allergy and Infectious Diseases
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases
Sun Yat-sen University
Clinical Trial Overview of Sun Yat-sen University
Third Affiliated Hospital of Sun Yat-sen University
Clinical Trial Overview of Third Affiliated Hospital of Sun Yat-sen University
Yonsei University
Clinical Trial Overview of Yonsei University
The Foundation for Liver Research
Clinical Trial Overview of The Foundation for Liver Research
Chinese University of Hong Kong
Clinical Trial Overview of Chinese University of Hong Kong
The University of Hong Kong
Clinical Trial Overview of The University of Hong Kong
French National Agency for Research on AIDS and Viral Hepatitis
Clinical Trial Overview of French National Agency for Research on AIDS and Viral Hepatitis
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source

LIST OF TABLES

Hepatitis B Therapeutics, Global, Clinical Trials by Region, 2014
Hepatitis B Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014
Hepatitis B Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014
Hepatitis B Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014
Hepatitis B Therapeutics Clinical Trials, Europe, Top Five Countries, 2014
Hepatitis B Therapeutics Clinical Trials, North America, Top Countries, 2014
Hepatitis B Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014
Hepatitis B Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014
Proportion of Hepatitis B to Infectious Disease Clinical Trials, G7 Countries (%), 2014
Hepatitis B Therapeutics, G7 Countries, Clinical Trials by Phase, 2014
Hepatitis B Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014
Proportion of Hepatitis B to Infectious Disease Clinical Trials, E7 Countries (%), 2014
Hepatitis B Therapeutics, E7 Countries, Clinical Trials by Phase, 2014
Hepatitis B Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014
Hepatitis B Therapeutics, Global, Clinical Trials by Phase, 2014
Hepatitis B Therapeutics, Global, Clinical Trials In Progress by Phase 2014
Hepatitis B Therapeutics, Global, Clinical Trials by Trial Status, 2014
Hepatitis B Therapeutics Clinical Trials, Global, by End Point Status, 2014
Hepatitis B Therapeutics, Global, Suspended Clinical Trials, 2014
Hepatitis B Therapeutics, Global, Withdrawn Clinical Trials, 2014
Hepatitis B Therapeutics, Global, Terminated Clinical Trials, 2014
Hepatitis B Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
Hepatitis B Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014
Hepatitis B Therapeutics Clinical Trials, Global, Key Sponsors, 2014
Hepatitis B Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014
Hepatitis B Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014
Hepatitis B Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014
Hepatitis B Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, Inc., 2014
Hepatitis B Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014
Hepatitis B Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014
Hepatitis B Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2014
Hepatitis B Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014
Hepatitis B Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014
Hepatitis B Therapeutics Clinical Trials Market, Global, Clinical Trials by Bukwang Pharm.Co., Ltd., 2014
Hepatitis B Therapeutics Clinical Trials Market, Global, Clinical Trials by Dynavax Technologies Corporation, 2014
Hepatitis B Therapeutics Clinical Trials Market, Global, Clinical Trials by LG Life Sciences, Ltd., 2014
Hepatitis B Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2014
Hepatitis B Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2014
Hepatitis B Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014
Hepatitis B Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Yat-sen University, 2014
Hepatitis B Therapeutics Clinical Trials Market, Global, Clinical Trials by Third Affiliated Hospital of Sun Yat-sen University, 2014
Hepatitis B Therapeutics Clinical Trials Market, Global, Clinical Trials by Yonsei University, 2014
Hepatitis B Therapeutics Clinical Trials Market, Global, Clinical Trials by The Foundation for Liver Research, 2014
Hepatitis B Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese University of Hong Kong, 2014
Hepatitis B Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Hong Kong, 2014
Hepatitis B Therapeutics Clinical Trials Market, Global, Clinical Trials by French National Agency for Research on AIDS and Viral Hepatitis, 2014

LIST OF FIGURES

Hepatitis B Therapeutics, Global, Clinical Trials by Region (%), 20147
Hepatitis B Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 20148
Hepatitis B Therapeutics, Global, Clinical Trials In Progress by Top Countries, 20149
Hepatitis B Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 201410
Hepatitis B Therapeutics Clinical Trials, Europe, Top Five Countries (%), 201411
Hepatitis B Therapeutics Clinical Trials, North America, Top Countries (%), 201412
Hepatitis B Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 201413
Hepatitis B Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 201414
Proportion of Hepatitis B to Infectious Disease Clinical Trials, G7 Countries (%), 201415
Hepatitis B Therapeutics, G7 Countries, Clinical Trials by Phase, 201416
Hepatitis B Therapeutics, G7 Countries, Clinical Trials by Trial Status, 201417
Proportion of Hepatitis B to Infectious Disease Clinical Trials, E7 Countries (%), 201418
Hepatitis B Therapeutics, E7 Countries, Clinical Trials by Phase, 201419
Hepatitis B Therapeutics, E7 Countries, Clinical Trials by Trial Status, 201420
Hepatitis B Therapeutics, Global, Clinical Trials by Phase (%), 201421
Hepatitis B Therapeutics, Global, Clinical Trials In Progress by Phase, 201422
Hepatitis B Therapeutics, Global, Clinical Trials by Trial Status, 201423
Hepatitis B Therapeutics Clinical Trials, Global, by End Point Status, 201424
Hepatitis B Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
Hepatitis B Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 201434
Hepatitis B Therapeutics Clinical Trials, Global, Key Sponsors, 201435
Hepatitis B Therapeutics Clinical Trials, Global, Top Companies by Phase, 201436
Hepatitis B Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 201438
GlobalData Methodology
Hepatic Injury Global Clinical Trials Review, Q1, 2011 US$ 1,000.00 Apr, 2011 · 31 pages
Hepatitis B Global Clinical Trials Review, Q2, 2011 US$ 1,000.00 Jun, 2011 · 81 pages
Hepatitis C Global Clinical Trials Review, Q2, 2011 US$ 1,000.00 Jun, 2011 · 84 pages
Hepatitis A Global Clinical Trials Review, Q2, 2011 US$ 1,000.00 Jun, 2011 · 46 pages
Hepatitis A Global Clinical Trials Review, H1, 2013 US$ 2,500.00 Jun, 2013 · 93 pages

Ask Your Question

Hepatitis B Global Clinical Trials Review, H2, 2014
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: